Atelvia (uh-TEL-vee-uh), a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis

February 2011

You'll see Atelvia (uh-TEL-vee-uh), a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis.

Atelvia will be promoted as more convenient because it's taken AFTER breakfast...instead of 30 to 60 minutes BEFORE breakfast like the other oral bisphosphonates.

Atelvia is designed to reduce interference with calcium, iron, and other cations that decrease bisphosphonate absorption.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote